OTCMKTS:MKGAY Merck KGaA (MKGAY) Stock Price, News & Analysis $38.36 0.00 (0.00%) As of 08/1/2017 Add Compare Share Share Stock Analysis Stock Analysis About Merck KGaA Stock (OTCMKTS:MKGAY) Get Merck KGaA alerts:Sign Up Key Stats Today's Range$38.36▼$38.3650-Day Range$38.36▼$38.3652-Week Range$32.53▼$42.02VolumeN/AAverage Volume6,872 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Merck KGaA is a Germany-based science and technology company that operates independently from the U.S. pharmaceutical company Merck & Co. The company serves customers worldwide through three business sectors: Healthcare, Life Science and Electronics. Its Healthcare business develops and markets prescription medicines and specialty products, including treatments in areas such as oncology, neurology and immunology, as well as fertility and endocrinology products. The Life Science business supplies laboratory chemicals, research materials, bioprocessing technologies and services used by pharmaceutical, biotechnology and academic customers. Merck KGaA’s Electronics business provides materials and solutions for the semiconductor and display industries, including specialty chemicals, thin-film materials and related technologies. Founded in Darmstadt, Germany, in 1668, the company has grown into a global organization with operations and customers across Europe, North America, Asia and other international markets. Belén Garijo serves as chair of the company’s executive board and chief executive officer.AI Generated. May Contain Errors. Read More Receive MKGAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MKGAY Stock News HeadlinesMerck KGaA and Remepy join forces to develop combo drug-digital therapiesApril 30, 2026 | msn.comMerck KGaA targets major shift to AI and human-centric drug testingApril 25, 2026 | msn.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.October 13 at 1:00 AM | Stansberry Research (Ad)Merck showcases data for Alzheimer’s Disease candidates at CTAD 2025December 1, 2025 | msn.comWhy Is Merck Stock Surging?November 26, 2025 | forbes.comMerck to present hematology pipeline data at ASH meetingNovember 24, 2025 | msn.comLexington biotech Valo Health lands deal worth up to $3B with Merck KGaANovember 20, 2025 | bizjournals.comMerck KGaA to draw on Valo's drug discovery AI in potential $3 billion dealNovember 20, 2025 | msn.comSee More Headlines MKGAY Stock Analysis - Frequently Asked Questions How have MKGAY shares performed this year? Merck KGaA's stock was trading at $38.36 on January 1st, 2026. Since then, MKGAY stock has increased by 0.0% and is now trading at $38.36. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:MKGAY CIKN/A WebN/A Phone496151720FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (OTCMKTS:MKGAY) was last updated on 8/1/2017 by MarketBeat.com Staff. From Our PartnersBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going t...Decentralized Masters | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | SponsoredElon Musk’s Hushed FCC Filing. Dec 8th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.